Live from the NIH registry
Studies recruiting near Deltona right now
Top 25 of 960 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Advanced Urology Institute - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: Pacific Edge Limited
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Advent Health Cancer Institute — Orlando, Florida (27.2 mi)
· Sponsor: Allogene Therapeutics
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Research Institute of Orlando, LLC — Orlando, Florida (27.2 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
AdventHealth — Altamonte Springs, Florida (19.2 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Orlando, Florida (27.2 mi)
· Sponsor: Dren Bio
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Central Florida Pulmonary Group — Orlando, Florida (27.2 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Orlando — Maitland, Florida (21.2 mi)
· Sponsor: RAI Services Company
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - North — Orange City, Florida (6.0 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (22.4 mi)
· Sponsor: AbbVie
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Mid Florida Hematology and Oncology Center ( Site 0152) — Orange City, Florida (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Orlando, Florida (27.2 mi)
· Sponsor: Sameek Roychowdhury
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
Advent Health Medical Group Urology — Orlando, Florida (27.2 mi)
· Sponsor: ImmVira Pharma Co. Ltd
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Orlando, Florida (27.2 mi)
· Sponsor: AstraZeneca
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
AdventHealth — Orlando, Florida (27.2 mi)
· Sponsor: DARTNet Institute
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Orange City, Florida (6.0 mi)
· Sponsor: Daiichi Sankyo
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Eli Lilly and Company
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU — DeLand, Florida (10.1 mi)
· Sponsor: Annovis Bio Inc.
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Clinical Neuroscience Solutions — Orlando, Florida (27.2 mi)
· Sponsor: Alveus Therapeutics, Inc.
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Arnold Palmer Children's Hospital — Orlando, Florida (27.2 mi)
· Sponsor: The Society for Pediatric Anesthesia
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: Giselle Sholler
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 130 participants sought
Orlando Health Cancer Institute — Orlando, Florida (27.2 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Halifax Health Cancer Center for Hope - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: NRG Oncology
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma
Phase 1
Interventional 448 participants sought
Research Site — Orlando, Florida (27.2 mi)
· Sponsor: Alterome Therapeutics, Inc.
Improving Mechanics and Confidence in the Hip Hinge
Hip Hinge, Hip and Knee Movement
N/A
Interventional 30 participants sought
University of Central Florida — Orlando, Florida (27.2 mi)
· Sponsor: University of Central Florida